StockWatch
·

NovaBay Pharmaceuticals, Inc.

Ticker: 1389545

values in millions

Revenue & Profit Trend

in millions
RevenueExpenditureNet Profit
-144.75117.94380.64643.33Q3 FY23Q1 FY24Q2 FY24Q3 FY24Q3 FY25Q1 FY26Q2 FY26Q3 FY26

Margin Trend

percentage
OPM %NPM %
-130.00-43.3343.33130.00Q3 FY23Q1 FY24Q2 FY24Q3 FY24Q3 FY25Q1 FY26Q2 FY26Q3 FY26
PeriodQ3 FY26Q2 FY26Q1 FY26Q3 FY25Q3 FY24Q2 FY24Q1 FY24Q3 FY23
INCOME
Revenue2.14-3.2%2.21-10.2%2.46+373.1%0.52-78.7%2.44+1.7%2.40-8.7%2.63-19.6%3.27
Total Income2.14-3.2%2.21-10.2%2.46+373.1%0.52-78.7%2.44+1.7%2.40-8.7%2.63-19.6%3.27
EXPENSES
Expenditure-53.82-196.0%56.05+382.7%-19.83-1214.0%1.78-49.1%3.50+1.4%3.45-32.0%5.07+15.8%4.38
Tax5.60+260.9%-3.48-200.9%3.450.00————
PROFIT
PBT55.96+225.6%-44.55-108.0%555.86————-1.76
Net Profit50.36+222.6%-41.07-107.4%552.40+42921.7%-1.29-6.6%-1.21+23.9%-1.59+50.5%-3.21-82.4%-1.76
KEY METRICS
OPM %100.00%+200.00pp-100.00%-200.00pp100.00%+200.00pp-100.00%-56.53pp-43.47%+0.41pp-43.88%+48.71pp-92.59%-58.41pp-34.18%
NPM %100.00%+200.00pp-100.00%-200.00pp100.00%+200.00pp-100.00%-50.35pp-49.65%+16.39pp-66.04%+33.96pp-100.00%-46.19pp-53.81%
EPS0.23+117.4%-1.32-106.2%21.23+9750.0%-0.22+63.3%-0.60+56.2%-1.37-813.3%-0.15+59.5%-0.37